Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Diagnostic Pathology
Published in: Diagnostic Pathology 1/2014

Open Access 01-12-2014 | Review

Association between Tumor necrosis factor-alpha gene polymorphisms and prostate cancer risk: a meta-analysis

Authors: Liping Ma, Jiangyang Zhao, Taijie Li, Yu He, Jian Wang, Li Xie, Xue Qin, Shan Li

Published in: Diagnostic Pathology | Issue 1/2014

Login to get access

Abstract

Background

Tumor necrosis factor-alpha (TNF-α) is an important inflammatory cytokine that may play a role in controlling the progression of prostate cancer. Two common polymorphisms in the TNF-α gene, −308G/A and −238C/T, have been suggested to alter the risk for prostate cancer, but the results have been inconclusive so far. In order to obtain a better understanding of the effects of these two polymorphisms on prostate cancer risk, all available studies were considered in a meta-analysis.

Methods

We conducted a comprehensive literature search in the Cochrane Library, PubMed, EMBASE, Chinese Biomedical Literature database (CBM), and the China National Knowledge Infrastructure (CNKI). The associations were evaluated by calculating the pooled odds ratio (OR) with 95% confidence interval (95% CI).

Results

In this meta-analysis, we included 14 studies with 5,757 patients and 6,137 control subjects for the TNF-α-308G/A polymorphism and 1,967 patients and 2,004 control subjects for the TNF-α-238C/T polymorphism. A significantly increased prostate cancer risk was found to be associated with the TNF-α-308C/T polymorphism in studies with healthy volunteers (AA + AG vs. GG: OR = 1.531, 95% CI = 1.093–2.145; P = 0.013; AG vs. GG: OR = 1.477, 95% CI = 1.047–2.085; P = 0.026). No significant association was found between the TNF-α-238G/A polymorphism and prostate cancer risk in the overall or subgroup analyses. There was no risk of publication bias in this meta-analysis.

Conclusions

Our results suggest that while the TNF-α-238G/A polymorphism may not be associated with prostate cancer the TNF-α-308C/T polymorphism may significantly contribute to prostate cancer susceptibility in healthy volunteers.

Virtual slides

The virtual slide(s) for this article can be found here: http://​www.​diagnosticpathol​ogy.​diagnomx.​eu/​vs/​1629288120116301​
Appendix
Available only for authorised users
Literature
1.
Siegel R, Naishadham D, Jemal A: Cancer statistics, 2013. CA: a cancer journal for clinicians. 2013, 63: 11-30. 10.3322/caac.21166.
2.
3.
Aronson KJ, Siemiatycki J, Dewar R, Gerin M: Occupational risk factors for prostate cancer: results from a case–control study in Montreal, Quebec, Canada. American journal of epidemiology. 1996, 143: 363-373. 10.1093/oxfordjournals.aje.a008750.PubMedCrossRef
4.
Hiatt RA, Armstrong MA, Klatsky AL, Sidney S: Alcohol consumption, smoking, and other risk factors and prostate cancer in a large health plan cohort in California (United States). Cancer causes & control: CCC. 1994, 5: 66-72. 10.1007/BF01830728.PubMedCrossRef
5.
Lichtenstein P, Holm NV, Verkasalo PK, Iliadou A, Kaprio J, Koskenvuo M, Pukkala E, Skytthe A, Hemminki K: Environmental and heritable factors in the causation of cancer–analyses of cohorts of twins from Sweden, Denmark, and Finland. The New England journal of medicine. 2000, 343: 78-85. 10.1056/NEJM200007133430201.PubMedCrossRef
6.
Kroeger KM, Carville KS, Abraham LJ: The −308 tumor necrosis factor-alpha promoter polymorphism effects transcription. Molecular immunology. 1997, 34: 391-399. 10.1016/S0161-5890(97)00052-7.PubMedCrossRef
7.
Merchant JL: Inflammation, atrophy, gastric cancer: connecting the molecular dots. Gastroenterology. 2005, 129: 1079-1082. 10.1053/j.gastro.2005.07.038.PubMedCrossRef
8.
Watts TH: TNF/TNFR family members in costimulation of T cell responses. Annual review of immunology. 2005, 23: 23-68. 10.1146/annurev.immunol.23.021704.115839.PubMedCrossRef
9.
Hoosein NM: Neuroendocrine and immune mediators in prostate cancer progression. Frontiers in bioscience: a journal and virtual library. 1998, 3: D1274-D1279.
10.
Fargion S, Valenti L, Dongiovanni P, Scaccabarozzi A, Fracanzani AL, Taioli E, Mattioli M, Sampietro M, Fiorelli G: Tumor necrosis factor alpha promoter polymorphisms influence the phenotypic expression of hereditary hemochromatosis. Blood. 2001, 97: 3707-3712. 10.1182/blood.V97.12.3707.PubMedCrossRef
11.
Valenti L, Fracanzani AL, Dongiovanni P, Santorelli G, Branchi A, Taioli E, Fiorelli G, Fargion S: Tumor necrosis factor alpha promoter polymorphisms and insulin resistance in nonalcoholic fatty liver disease. Gastroenterology. 2002, 122: 274-280. 10.1053/gast.2002.31065.PubMedCrossRef
12.
D'Alfonso S, Richiardi PM: A polymorphic variation in a putative regulation box of the TNFA promoter region. Immunogenetics. 1994, 39: 150-154.PubMed
13.
Wilson AG, Symons JA, McDowell TL, McDevitt HO, Duff GW: Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation. Proceedings of the National Academy of Sciences of the United States of America. 1997, 94: 3195-3199. 10.1073/pnas.94.7.3195.PubMedPubMedCentralCrossRef
14.
Saenz-Lopez P, Carretero R, Cozar JM, Romero JM, Canton J, Vilchez JR, Tallada M, Garrido F, Ruiz-Cabello F: Genetic polymorphisms of RANTES, IL1-A, MCP-1 and TNF-A genes in patients with prostate cancer. BMC cancer. 2008, 8: 382-PubMedPubMedCentralCrossRef
15.
Danforth KN, Rodriguez C, Hayes RB, Sakoda LC, Huang WY, Yu K, Calle EE, Jacobs EJ, Chen BE, Andriole GL, Figueroa JD, Yeager M, Platz EA, Michaud DS, Chanock SJ, Thun MJ, Hsing AW: TNF polymorphisms and prostate cancer risk. The Prostate. 2008, 68: 400-407. 10.1002/pros.20694.PubMedCrossRef
16.
Oh BR, Sasaki M, Perinchery G, Ryu SB, Park YI, Carroll P, Dahiya R: Frequent genotype changes at −308, and 488 regions of the tumor necrosis factor-alpha (TNF-alpha) gene in patients with prostate cancer. The Journal of urology. 2000, 163: 1584-1587. 10.1016/S0022-5347(05)67683-5.PubMedCrossRef
17.
Wang J, Cao C, Luo H, Xiong S, Xu Y, Xiong W: Tumour necrosis factor alpha -308G/A polymorphism and risk of the four most frequent cancers: a meta-analysis. International journal of immunogenetics. 2011, 38: 311-320. 10.1111/j.1744-313X.2011.01014.x.PubMedCrossRef
18.
Thakkinstian A, McEvoy M, Minelli C, Gibson P, Hancox B, Duffy D, Thompson J, Hall I, Kaufman J, Leung TF, Helms PJ, Hakonarson H, Halpi E, Navon R, Attia J: Systematic review and meta-analysis of the association between {beta}2-adrenoceptor polymorphisms and asthma: a HuGE review. American journal of epidemiology. 2005, 162: 201-211. 10.1093/aje/kwi184.PubMedCrossRef
19.
Higgins JP, Thompson SG, Deeks JJ, Altman DG: Measuring inconsistency in meta-analyses. BMJ (Clinical research ed). 2003, 327: 557-560. 10.1136/bmj.327.7414.557.CrossRef
20.
Mantel N, Haenszel W: Statistical aspects of the analysis of data from retrospective studies of disease. Journal of the National Cancer Institute. 1959, 22: 719-748.PubMed
21.
DerSimonian R, Laird N: Meta-analysis in clinical trials. Controlled Clinical Trials. 1986, 7: 177-188. 10.1016/0197-2456(86)90046-2.PubMedCrossRef
22.
Egger M, Davey Smith G, Schneider M, Minder C: Bias in meta-analysis detected by a simple, graphical test. BMJ (Clinical research ed). 1997, 315: 629-634. 10.1136/bmj.315.7109.629.CrossRef
23.
Duval S, Tweedie R: Trim and fill: A simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis. Biometrics. 2000, 56: 455-463. 10.1111/j.0006-341X.2000.00455.x.PubMedCrossRef
24.
Mangyuan W, Zhenwei H, Jiaming L, Banghua L: TNF-α gene–308 G/A polymorphism and the risk of prostate cancer: A Meta-Analysis. Chin J Evid-based Med. 2012, 8: 1030-1034.
25.
Ribeiro RJ, Monteiro CP, Azevedo AS, Cunha VF, Ramanakumar AV, Fraga AM, Pina FM, Lopes CM, Medeiros RM, Franco EL: Performance of an adipokine pathway-based multilocus genetic risk score for prostate cancer risk prediction. PloS one. 2012, 7: e39236-10.1371/journal.pone.0039236.PubMedPubMedCentralCrossRef
26.
Berhane N, Sobti RC, Melesse S, Mahdi SA, Kassu A: Significance of Tumor necrosis factor alpha-308 (G/A) gene polymorphism in the development of prostate cancer. Molecular biology reports. 2012, 39: 11125-11130. 10.1007/s11033-012-2020-2.PubMedCrossRef
27.
Wang MH, Helzlsouer KJ, Smith MW, Hoffman-Bolton JA, Clipp SL, Grinberg V, De Marzo AM, Isaacs WB, Drake CG, Shugart YY, Platz EA: Association of IL10 and other immune response- and obesity-related genes with prostate cancer in CLUE II. The Prostate. 2009, 69: 874-885. 10.1002/pros.20933.PubMedPubMedCentralCrossRef
28.
Moore SC, Leitzmann MF, Albanes D, Weinstein SJ, Snyder K, Virtamo J, Ahn J, Mayne ST, Yu H, Peters U, Gunter MJ: Adipokine genes and prostate cancer risk. International journal of cancer Journal international du cancer. 2009, 124: 869-876. 10.1002/ijc.24043.PubMedPubMedCentralCrossRef
29.
Kesarwani P, Mandhani A, Mittal RD: Polymorphisms in tumor necrosis factor-A gene and prostate cancer risk in North Indian cohort. The Journal of urology. 2009, 182: 2938-2943. 10.1016/j.juro.2009.08.016.PubMedCrossRef
30.
Zabaleta J, Lin HY, Sierra RA, Hall MC, Clark PE, Sartor OA, Hu JJ, Ochoa AC: Interactions of cytokine gene polymorphisms in prostate cancer risk. Carcinogenesis. 2008, 29: 573-578.PubMedCrossRef
31.
Ge J: Studies on the relationship between single nucleotide polymorphisms and susceptibility to Prostate cancer in Chinese population. 2007, Soochow University: Master’s thesis, doi:10.7666/d.y1178232
32.
Wu HC, Chang CH, Chen HY, Tsai FJ, Tsai JJ, Chen WC: p53 gene codon 72 polymorphism but not tumor necrosis factor-alpha gene is associated with prostate cancer. Urologia internationalis. 2004, 73: 41-46. 10.1159/000078803.PubMedCrossRef
33.
McCarron SL, Edwards S, Evans PR, Gibbs R, Dearnaley DP, Dowe A, Southgate C, Easton DF, Eeles RA, Howell WM: Influence of cytokine gene polymorphisms on the development of prostate cancer. Cancer research. 2002, 62: 3369-3372.PubMed
34.
Locksley RM, Killeen N, Lenardo MJ: The TNF and TNF receptor superfamilies: integrating mammalian biology. Cell. 2001, 104: 487-501. 10.1016/S0092-8674(01)00237-9.PubMedCrossRef
35.
Balkwill F: TNF-alpha in promotion and progression of cancer. Cancer metastasis reviews. 2006, 25: 409-416. 10.1007/s10555-006-9005-3.PubMedCrossRef
36.
Dranoff G: Cytokines in cancer pathogenesis and cancer therapy. Nature reviews Cancer. 2004, 4: 11-22. 10.1038/nrc1252.PubMedCrossRef
37.
Beutler B, Cerami A: The biology of cachectin/TNF–a primary mediator of the host response. Annual review of immunology. 1989, 7: 625-655. 10.1146/annurev.iy.07.040189.003205.PubMedCrossRef
38.
Raabe T, Bukrinsky M, Currie RA: Relative contribution of transcription and translation to the induction of tumor necrosis factor-alpha by lipopolysaccharide. The Journal of biological chemistry. 1998, 273: 974-980. 10.1074/jbc.273.2.974.PubMedCrossRef
39.
Bidwell J, Keen L, Gallagher G, Kimberly R, Huizinga T, McDermott MF, Oksenberg J, McNicholl J, Pociot F, Hardt C, D'Alfonso S: Cytokine gene polymorphism in human disease: on-line databases. Genes and immunity. 1999, 1: 3-19. 10.1038/sj.gene.6363645.PubMedCrossRef
40.
Yang Y, Luo C, Feng R, Bi S: The TNF-alpha, IL-1B and IL-10 polymorphisms and risk for hepatocellular carcinoma: a meta-analysis. Journal of cancer research and clinical oncology. 2011, 137: 947-952. 10.1007/s00432-010-0959-8.PubMedCrossRef
41.
Shen C, Sun H, Sun D, Xu L, Zhang X, Liu A, Jia X, Bai J, Chen F, Yu Y, Jin Y, Yu J, Fu S: Polymorphisms of tumor necrosis factor-alpha and breast cancer risk: a meta-analysis. Breast cancer research and treatment. 2011, 126: 763-770. 10.1007/s10549-010-1184-5.PubMedCrossRef
42.
Lu PH, Tang Y, Li C, Shen W, Ji L, Guo YJ, Tao GQ: [Meta-analysis of association of tumor necrosis factor alpha-308 gene promoter polymorphism with gastric cancer]. Zhonghua yu fang yi xue za zhi [Chinese journal of preventive medicine]. 2010, 44: 209-214.
43.
Kaluza W, Reuss E, Grossmann S, Hug R, Schopf RE, Galle PR, Maerker-Hermann E, Hoehler T: Different transcriptional activity and in vitro TNF-alpha production in psoriasis patients carrying the TNF-alpha 238A promoter polymorphism. The Journal of investigative dermatology. 2000, 114: 1180-1183. 10.1046/j.1523-1747.2000.00001.x.PubMedCrossRef
44.
Hohler T, Kruger A, Gerken G, Schneider PM, Meyer Zum Buschenefelde KH, Rittner C: A tumor necrosis factor-alpha (TNF-alpha) promoter polymorphism is associated with chronic hepatitis B infection. Clinical and experimental immunology. 1998, 111: 579-582. 10.1046/j.1365-2249.1998.00534.x.PubMedPubMedCentralCrossRef
45.
Brinkman BM, Huizinga TW, Kurban SS, van der Velde EA, Schreuder GM, Hazes JM, Breedveld FC, Verweij CL: Tumour necrosis factor alpha gene polymorphisms in rheumatoid arthritis: association with susceptibility to, or severity of, disease?. British journal of rheumatology. 1997, 36: 516-521. 10.1093/rheumatology/36.5.516.PubMedCrossRef
46.
Cheng D, Shi H, Zhang K, Yi L, Zhen G: RAD51 Gene 135G/C polymorphism and the risk of four types of common cancers: a meta-analysis. Diagnostic pathology. 2014, 9: 18-10.1186/1746-1596-9-18.PubMedPubMedCentralCrossRef
47.
Wang L, Cai S, Teng Z, Zhao X, Chen X, Bai X: Insulin therapy contributes to the increased risk of colorectal cancer in diabetes patients: a meta-analysis. Diagnostic pathology. 2013, 8: 180-10.1186/1746-1596-8-180.PubMedPubMedCentralCrossRef
48.
Yu L, Chen J: Association of MTHFR Ala222Val (rs1801133) polymorphism and breast cancer susceptibility: An update meta-analysis based on 51 research studies. Diagnostic pathology. 2012, 7: 171-10.1186/1746-1596-7-171.PubMedPubMedCentralCrossRef
49.
Fujisawa T, Ikegami H, Kawaguchi Y, Ogihara T: Meta-analysis of the association of Trp64Arg polymorphism of beta 3-adrenergic receptor gene with body mass index. The Journal of clinical endocrinology and metabolism. 1998, 83: 2441-2444.PubMed
Metadata
Title
Association between Tumor necrosis factor-alpha gene polymorphisms and prostate cancer risk: a meta-analysis
Authors
Liping Ma
Jiangyang Zhao
Taijie Li
Yu He
Jian Wang
Li Xie
Xue Qin
Shan Li
Publication date
01-12-2014
Publisher
BioMed Central
Published in
Diagnostic Pathology / Issue 1/2014
Electronic ISSN: 1746-1596
DOI
https://doi.org/10.1186/1746-1596-9-74

Other articles of this Issue 1/2014

Diagnostic Pathology 1/2014 Go to the issue

Case Report

Giant pelvic angiomyofibroblastoma: case report and literature review

Research

Follow-up of breast papillary lesion on core needle biopsy: experience in African-American population

Research

Difference in distribution profiles between CD163+ tumor-associated macrophages and S100+ dendritic cells in thymic epithelial tumors

Research

Up-regulation of miR-9 expression predicate advanced clinicopathological features and poor prognosis in patients with hepatocellular carcinoma

Research

The NQO1 Pro187Ser polymorphism and breast cancer susceptibility: evidence from an updated meta-analysis

Research

Decreased microRNA-224 and its clinical significance in non-small cell lung cancer patients